These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion. Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378 [TBL] [Abstract][Full Text] [Related]
8. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply. Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504 [TBL] [Abstract][Full Text] [Related]
9. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks. Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052 [TBL] [Abstract][Full Text] [Related]
10. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Seo DH; Whang DH; Song EY; Kim HS; Park Q Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731 [TBL] [Abstract][Full Text] [Related]
12. Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme. Seed CR; Maloney R; Kiely P; Bell B; Keller AJ; Pink J; Vox Sang; 2015 Feb; 108(2):113-22. PubMed ID: 25234417 [TBL] [Abstract][Full Text] [Related]
13. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. Liu CJ; Lo SC; Kao JH; Tseng PT; Lai MY; Ni YH; Yeh SH; Chen PJ; Chen DS J Hepatol; 2006 Jan; 44(1):39-46. PubMed ID: 16168517 [TBL] [Abstract][Full Text] [Related]
14. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866 [TBL] [Abstract][Full Text] [Related]
18. A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening. Seed CR; Kiely P Vox Sang; 2013 Nov; 105(4):290-8. PubMed ID: 23802710 [TBL] [Abstract][Full Text] [Related]
19. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990 [TBL] [Abstract][Full Text] [Related]
20. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors. Muselmani W; Habbal W; Monem F Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]